Citations to this article

Gerald W. Dorn II, Thomas Force
Published in Volume 115, Issue 3
J Clin Invest. 2005; 115(3):527–537 doi:10.1172/JCI24178

Total citations by year in Crossref

Year: 2013 2012 2011 2009 2008 2007 2006 2005 Total
Citations: 1 1 3 3 7 13 11 5 44
Citation information

Citations to this article in Crossref (44)

Title and authors Publication Year
Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo
F Billia, L Hauck, D Grothe, F Konecny, V Rao, RH Kim, TW Mak
Proceedings of the National Academy of Sciences 2013
Redox regulation of sodium and calcium handling
S Wagner, A Rokita, ME Anderson, LS Maier
Antioxidants & Redox Signaling 2012
Selective deletion of long but not short Cypher isoforms leads to late-onset dilated cardiomyopathy
H Cheng, M Zheng, AK Peter, K Kimura, X Li, K Ouyang, T Shen, L Cui, D Frank, ND Dalton, Y Gu, N Frey, KL Peterson, SM Evans, KU Knowlton, F Sheikh, J Chen
Human Molecular Genetics 2011
Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart Size
M Xin, Y Kim, LB Sutherland, X Qi, J McAnally, RJ Schwartz, JA Richardson, R Bassel-Duby, EN Olson
Science signaling 2011
Scaffold-Based Transplantation of Akt1 -Overexpressing Skeletal Myoblasts: Functional Regeneration Is Associated with Angiogenesis and Reduced Infarction Size
M Siepe, P Golsong, A Poppe, B Blumenthal, R Wattenwyl, C Heilmann, K Förster, C Schlensak, F Beyersdorf
Tissue Engineering Part A 2011
CHF1/Hey2 Promotes Physiological Hypertrophy in Response to Pressure Overload through Selective Repression and Activation of Specific Transcriptional Pathways
M Yu, Y Liu, F Xiang, Y Li, D Cullen, R Liao, RP Beyer, TK Bammler, MT Chin
OMICS: A Journal of Integrative Biology 2009
Regulation of phospholipase C in cardiac hypertrophy
PS Tappia, T Singal
Clinical Lipidology 2009
Selective activation of PI3K /Akt/GSK-3  signalling and cardiac compensatory hypertrophy during recovery from heart failure
JC Braz, RM Gill, AK Corbly, BD Jones, N Jin, CJ Vlahos, Q Wu, W Shen
European Journal of Heart Failure 2009
Novel signalling cascade for cardiac hypertrophy activation by uncoupling and internalization of  1-adrenoceptors
M Endoh
Cardiovascular Research 2008
Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes
JS Martini, P Raake, LE Vinge, BR DeGeorge, B DeGeorge, JK Chuprun, DM Harris, E Gao, AD Eckhart, JA Pitcher, WJ Koch
Proceedings of the National Academy of Sciences 2008
Genomics in cardiac metabolism
JL Samuel, MC Schaub, M Zaugg, M Mamas, WB Dunn, B Swynghedauw
Cardiovascular Research 2008
Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning: role of HIF1  and CREB
J Feng, E Lucchinetti, G Fischer, M Zhu, K Zaugg, MC Schaub, M Zaugg
Cardiovascular Research 2008
A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
K Lorenz, JP Schmitt, EM Schmitteckert, MJ Lohse
Nature Medicine 2008
Effects of Hawthorn on Cardiac Remodeling and Left Ventricular Dysfunction after 1 Month of Pressure Overload-induced Cardiac Hypertrophy in Rats
HS Hwang, BE Bleske, MM Ghannam, K Converso, MW Russell, JC Hunter, MO Boluyt
Cardiovascular Drugs and Therapy 2008
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
GW 2nd
Cardiovascular Research 2008
Cardiac Hypertrophy: Mechanisms and Therapeutic Opportunities
S Gupta, B Das, S Sen
Antioxidants & Redox Signaling 2007
Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy
G Simonis, SK Briem, SP Schoen, M Bock, R Marquetant, RH Strasser
Molecular and Cellular Biochemistry 2007
The upper limit of physiological cardiac hypertrophy in elite male and female athletes in China
European Journal of Applied Physiology 2007
Glycogen Synthase Kinase-3β—Actively Inhibiting Hypertrophy
R Kerkelä, K Woulfe, T Force
Trends in Cardiovascular Medicine 2007
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity
CM Trivedi, Y Luo, Z Yin, M Zhang, W Zhu, T Wang, T Floss, M Goettlicher, PR Noppinger, W Wurst, VA Ferrari, CS Abrams, PJ Gruber, JA Epstein
Nature Medicine 2007
Reversal of cardiac remodeling by modulation of adrenergic receptors: a new frontier in heart failure:
C Perrino, HA Rockman
Current Opinion in Cardiology 2007
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy
OJ Kemi, M Ceci, U Wisloff, S Grimaldi, P Gallo, GL Smith, G Condorelli, O Ellingsen
Journal of Cellular Physiology 2007
Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice
A Diwan, M Krenz, FM Syed, J Wansapura, X Ren, AG Koesters, H Li, LA Kirshenbaum, HS Hahn, J Robbins, WK Jones, GW Dorn
Journal of Clinical Investigation 2007
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface
TA McKinsey, DA Kass
Nature Reviews Drug Discovery 2007
Oxidative stress activates insulin-like growth factor I receptor protein expression, mediating cardiac hypertrophy induced by thyroxine
AS Araujo, AT Enzveiler, P Schenkel, TR Fernandes, MF Ribeiro, WA Partata, S Llesuy, A Belló-Klein
Molecular and Cellular Biochemistry 2007